EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis

Haoran Wang iD, Jiankang Mu, Yexing Chen, Yali Liu, Xianghui Li, Hao Li, Peng Cao

Advanced Science · 2024

DOI: 10.1002/advs.202308235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Haoran Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Provincial Medical Innovation Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chine…. Hauptthemen laut MEDLINE: Cancer Vaccines, Extracellular Vesicles, Panax, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jiangsu Provincial Medical Innovation Center, Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine, Fundamental Research Funds of Nanjing Universities of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Personalized cancer vaccines based on resected tumors from patients is promising to address tumor heterogeneity to inhibit tumor recurrence or metastasis. However, it remains challenge to elicit immune activation due to the weak immunogenicity of autologous tumor antigens. Here, a hybrid membrane cancer vaccine is successfully constructed by membrane fusion to enhance adaptive immune response and amplify personalized immunotherapy, which formed a codelivery system for autologous tumor antigens and immune adjuvants. Briefly, the functional hybrid vesicles (HM‐NPs) are formed by hybridizing ginseng‐derived extracellular vesicles‐like particles (G‐EVLPs) with the membrane originated from the resected autologous tumors. The introduction of G‐EVLPs can enhance the phagocytosis of autologous tumor antigens by dendritic cells (DCs) and facilitate DCs maturation through TLR4, ultimately activating tumor‐specific cytotoxic T lymphocytes (CTLs). HM‐NPs can indeed strengthen specific immune responses to suppress tumors recurrence and metastasis including subcutaneous tumors and orthotopic tumors. Furthermore, a long‐term immune protection can be obtained after vaccinating with HM‐NPs, and prolonging the survival of animals. Overall, this personalized hybrid autologous tumor vaccine based on G‐EVLPs provides the possibility of mitigating tumor recurrence and metastasis after surgery while maintaining good biocompatibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesExtracellular VesiclesPanaxNeoplasm Recurrence, LocalAnimalsMicePrecision MedicineDisease Models, AnimalCell MembraneHumansNeoplasm MetastasisVaccinationDendritic CellsFemaleCell Line, Tumor

Stichwörter der Autor:innen

ginseng‐derived nanoparticleshybrid nanoparticleslong‐term protectionmature DCspersonalized tumor vaccine

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • Jiangsu Provincial Medical Innovation Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, 210028, China.
  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
  • Department of Dermatology, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.
  • Chinatalentgroup (CTG Group), Beijing, 100020, China.

ORCID-Profile: Haoran Wang

Förderung

  • Jiangsu Provincial Medical Innovation Center
  • Jiangsu Province's Outstanding Leader Program of Traditional Chinese Medicine
  • Fundamental Research Funds of Nanjing Universities of Chinese Medicine
  • Natural Science Foundation of Jiangsu Province
  • National Natural Science Foundation of China
  • Jiangsu Provincial Key Research and Development Program
  • Key Technologies Research and Development Program
  • National Outstanding Youth Science Fund Project of National Natural Science Foundation of China

Zitieren

APA

Wang, H., Mu, J., Chen, Y., Liu, Y., Li, X., Li, H., & Cao, P. (2024). Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis. Advanced Science. https://doi.org/10.1002/advs.202308235

Vancouver

Wang H, Mu J, Chen Y, Liu Y, Li X, Li H, et al. Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis. Advanced Science. 2024. doi:10.1002/advs.202308235

BibTeX
@article{Wang2024,
  author = {Wang, Haoran and Mu, Jiankang and Chen, Yexing and Liu, Yali and Li, Xianghui and Li, Hao and Cao, Peng},
  title = {Hybrid Ginseng‐derived Extracellular Vesicles‐Like Particles with Autologous Tumor Cell Membrane for Personalized Vaccination to Inhibit Tumor Recurrence and Metastasis},
  journal = {Advanced Science},
  year = {2024},
  doi = {10.1002/advs.202308235}
}
Kostenlos starten →